Isolated Maternal Hypothyroxinemia: Adverse Maternofetal Outcomes but Uncertainty About Treatment Remains
- PMID: 36987374
- PMCID: PMC10325797
- DOI: 10.1089/thy.2023.0152
Isolated Maternal Hypothyroxinemia: Adverse Maternofetal Outcomes but Uncertainty About Treatment Remains
Conflict of interest statement
E.N.P. has received honoraria for speaking and workshop participation from the National Dairy Council.
References
-
- Vermiglio F, Lo Presti VP, Castagna MG, et al. . Increased risk of maternal thyroid failure with pregnancy progression in an iodine deficient area with major iodine deficiency disorders. Thyroid 1999;9(1):19–24. - PubMed
-
- Pop VJ, Kuijpens JL, van Baar AL, et al. . Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999;50(2):149–155. - PubMed
-
- Dong AC, Stagnaro-Green A. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: A systematic review and meta-analysis. Thyroid 2019;29(2):278–289. - PubMed
-
- Dosiou C, Medici M. Management of endocrine disease: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns. Eur J Endocrinol 2017;176(1):R21–R38. - PubMed
-
- Pearce EN. Management of hypothyroidism and hypothyroxinemia during pregnancy. Endocr Pract 2022;28(7):711–718. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical